Samir Hanash Selected Research

Samir Hanash Research Topics

Disease

59	Neoplasms (Cancer) 08/2022 - 06/2002
12	Breast Neoplasms (Breast Cancer) 05/2021 - 10/2002
9	Lung Neoplasms (Lung Cancer) 09/2021 - 12/2002
7	Adenocarcinoma of Lung 05/2022 - 08/2002
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 11/2004
6	Inflammation (Inflammations) 01/2018 - 06/2003
5	Triple Negative Breast Neoplasms 01/2022 - 08/2015
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 01/2010
4	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2016 - 11/2013
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 11/2003
3	Carcinoma (Carcinomatosis) 04/2007 - 03/2005
2	Carcinogenesis 05/2021 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 01/2016
2	Leukemia 01/2020 - 01/2016
2	Bronchiolitis Obliterans Syndrome 01/2020 - 08/2017
2	Adenocarcinoma 01/2019 - 11/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2009 - 02/2009
2	Endometrioid Carcinoma 04/2007 - 03/2005
2	Liver Diseases (Liver Disease) 11/2006 - 09/2004
2	Colorectal Neoplasms (Colorectal Cancer) 07/2005 - 11/2002
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2021
1	Rectal Neoplasms (Rectal Cancer) 07/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2021
1	Ovarian Neoplasms (Ovarian Cancer) 02/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Disease Progression 01/2020

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2002
22	Biomarkers (Surrogate Marker)IBA 07/2021 - 10/2002
9	ProteomeIBA 01/2019 - 08/2002
8	AntigensIBA 05/2021 - 01/2004
7	OligonucleotidesIBA 03/2005 - 11/2002
6	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 05/2003
6	Biological ProductsIBA 09/2021 - 10/2002
5	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 04/2006
5	Neoplasm Antigens (Tumor Antigens)IBA 05/2021 - 11/2003
4	RNA (Ribonucleic Acid)IBA 08/2022 - 01/2005
4	AutoantibodiesIBA 05/2021 - 01/2004
4	Messenger RNA (mRNA)IBA 01/2020 - 12/2004
3	LipidsIBA 06/2022 - 01/2020
3	Blood Proteins (Serum Proteins)IBA 07/2021 - 05/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 06/2003
3	Surface-Active Agents (Surfactants)IBA 11/2015 - 10/2013
3	IgA receptor (protein B)IBA 11/2015 - 10/2013
3	beta CateninIBA 04/2007 - 06/2002
2	EnzymesIBA 05/2022 - 03/2005
2	Protein Isoforms (Isoforms)IBA 10/2021 - 09/2002
2	Immunoglobulin G (IgG)IBA 05/2021 - 06/2013
2	PolyaminesIBA 02/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2020 - 08/2015
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	N',N''-diacetylspermineIBA 01/2020 - 11/2015
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Polysaccharides (Glycans)IBA 04/2016 - 06/2011
2	Long Noncoding RNAIBA 02/2016 - 02/2016
2	Cadherins (E-Cadherin)IBA 01/2016 - 11/2002
2	Immunoglobulins (Immunoglobulin)IBA 03/2013 - 11/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 05/2012 - 08/2009
2	Tumor Biomarkers (Tumor Markers)IBA 09/2007 - 01/2004
2	CytokinesIBA 01/2003 - 12/2002
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	KynurenineIBA 05/2022
1	kynureninaseIBA 05/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	Thyroid Nuclear Factor 1IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Proline (L-Proline)FDA Link 10/2021
1	Alanine (L-Alanine)FDA Link 10/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2021
1	Cathepsin BIBA 07/2021
1	Insulin-Like Growth Factor Binding Protein 4IBA 07/2021
1	EpitopesIBA 05/2021
1	Ribosomal DNA (rDNA)IBA 11/2020
1	CholesterolIBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	amsonic acid (DAS)IBA 01/2020
1	GlycosphingolipidsIBA 01/2020
1	SphingomyelinsIBA 01/2020
1	SphingolipidsIBA 01/2020
1	Spermine SynthaseIBA 01/2020
1	SpermineIBA 01/2020
1	CeramidesIBA 01/2020
1	Caveolin 1IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Syndecan-1 (Syndecan 1)IBA 01/2019
1	LeptinIBA 01/2018
1	Serine Proteases (Serine Protease)IBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Myeloblastin (Proteinase 3)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2017
1	Fibrinogen (Factor I)FDA Link 02/2016
1	Glutamine (L-Glutamine)FDA Link 02/2016

Therapy/Procedure

12	Therapeutics 08/2022 - 08/2002
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2007
4	Cell Transplantation 01/2019 - 10/2015
3	Immunotherapy 01/2019 - 01/2007
1	Neoadjuvant Therapy 07/2021